Datasetspublic full text
ClinicalTrials.gov
clinicaltrials · Datasets · License: Public Domain
182,442Documents
1,450Full text
2026-10-01Last indexed
Recent documents from this source
- A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group#143666
- Safety, Immunogenicity, and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy Participants#143665
- Zambia SiVET MMR Tdap-IPV#143664
- ICVAX as a HIV Therapeutic DNA Vaccine#143663
- Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age#143662
- Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer#143661
- Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19#143660
- Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older#143659
- PREVENT Pilot HPV - Related Cancers Trial#143658
- Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine#143657
- A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants#143656
- Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults#143655
- A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules#143654
- Fourth Dose of mRNA COVID-19 Vaccine in Residents of LTCFs#143653
- Thimble Mindfulness App and Recovery Patch Descriptions#143652
- A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa#143651
- Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine#143650
- Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha)#143649
- Phase II Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine#143648
- Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010#143647
Source record · clinicaltrials · Datasets · License: Public Domain
Conceptio Open Knowledge Archive — counts are materialised per sync from the index (real full-text coverage, never license entitlement).